ConductScience.org, home

Paper25751786

Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?

Farrugia BL and 3 others. Molecules, 2015. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard? Papers, record 25751786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25751786

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?
PubMed
Journal
Molecules
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2026-01-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farrugia BLBrooke L
2Lord MSMegan S
3Melrose JJames
4Whitelock JMJohn M

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
BiomimeticsMajor topic
HeparinMajor topic
Heparan SulfateMajor topic
Animals
Humans

References124

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122034431Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.Science2011https://conductscience.org/library/papers/22034431PubMed
223240683Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction.J Am Chem Soc2012https://conductscience.org/library/papers/23240683PubMed
318437154Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.Nat Biotechnol2008https://conductscience.org/library/papers/18437154PubMed
424697306Fluorous-assisted chemoenzymatic synthesis of heparan sulfate oligosaccharides.Org Lett2014https://conductscience.org/library/papers/24697306PubMed
521697878Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction.Nat Chem2011https://conductscience.org/library/papers/21697878PubMed
69468484Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development.J Biol Chem1998https://conductscience.org/library/papers/9468484PubMed
724770491Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.Glycobiology2014https://conductscience.org/library/papers/24770491PubMed
810600481Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.Biochem Biophys Res Commun1999https://conductscience.org/library/papers/10600481PubMed
916011323Heparan sulfate: a complex polymer charged with biological activity.Chem Rev2005https://conductscience.org/library/papers/16011323PubMed
1024247246Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.J Biol Chem2013https://conductscience.org/library/papers/24247246PubMed
1119131102Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.Biomaterials2009https://conductscience.org/library/papers/19131102PubMed
1210080934Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.Biochem Biophys Res Commun1999https://conductscience.org/library/papers/10080934PubMed
1324038939Tailored design and synthesis of heparan sulfate oligosaccharide analogues using sequential one-pot multienzyme systems.Angew Chem Int Ed Engl2013https://conductscience.org/library/papers/24038939PubMed
1420161474Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.Nat Chem2009https://conductscience.org/library/papers/20161474PubMed
1524140042Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorporating BMP-2.Biomaterials2014https://conductscience.org/library/papers/24140042PubMed
167779094Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.Biochem Biophys Res Commun1995https://conductscience.org/library/papers/7779094PubMed
1711545306Anticoagulant potential of regioselective derivatized cellulose.Biomaterials2001https://conductscience.org/library/papers/11545306PubMed
189020150Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis.J Biol Chem1997https://conductscience.org/library/papers/9020150PubMed
1915658847Generation of "neoheparin" from E. coli K5 capsular polysaccharide.J Med Chem2005https://conductscience.org/library/papers/15658847PubMed
2020729556Chemoenzymatic design of heparan sulfate oligosaccharides.J Biol Chem2010https://conductscience.org/library/papers/20729556PubMed

See all 124 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41238912Engineering a heparin-mimetic biomaterial to promote tissue vascularization.Commun Biol2025https://conductscience.org/library/papers/41238912PubMed
40705086The Role of Heparan Sulfate in Bone Repair and Regeneration.Calcif Tissue Int2025https://conductscience.org/library/papers/40705086PubMed
32947045Advances in the preparation and synthesis of heparin and related products.Drug Discov Today2020https://conductscience.org/library/papers/32947045PubMed
29290139Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.J Histochem Cytochem2018https://conductscience.org/library/papers/29290139PubMed
29160016Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.ChemMedChem2018https://conductscience.org/library/papers/29160016PubMed
28505124Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors.Molecules2017https://conductscience.org/library/papers/28505124PubMed
28468328Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.Molecules2017https://conductscience.org/library/papers/28468328PubMed
28029141Glycosaminoglycans and Their Mimetics.Molecules2016https://conductscience.org/library/papers/28029141PubMed
27744271Surprising absence of heparin in the intestinal mucosa of baby pigs.Glycobiology2017https://conductscience.org/library/papers/27744271PubMed
27461855Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.Adv Mater2016https://conductscience.org/library/papers/27461855PubMed
26554451Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate.J Transl Med2015https://conductscience.org/library/papers/26554451PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGRN375790PubTator's text mininghttps://conductscience.org/library/genes/375790NCBI Gene
ALPP250PubTator's text mininghttps://conductscience.org/library/genes/250NCBI Gene
BMP2650PubTator's text mininghttps://conductscience.org/library/genes/650NCBI Gene
BMP4652PubTator's text mininghttps://conductscience.org/library/genes/652NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CS1431PubTator's text mininghttps://conductscience.org/library/genes/1431NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
FGF12246PubTator's text mininghttps://conductscience.org/library/genes/2246NCBI Gene
FGF22247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
GPC12817PubTator's text mininghttps://conductscience.org/library/genes/2817NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HS3ST19957PubTator's text mininghttps://conductscience.org/library/genes/9957NCBI Gene
HS6ST19394PubTator's text mininghttps://conductscience.org/library/genes/9394NCBI Gene
SERPINC1462PubTator's text mininghttps://conductscience.org/library/genes/462NCBI Gene
SPARC6678PubTator's text mininghttps://conductscience.org/library/genes/6678NCBI Gene
SRGN5552PubTator's text mininghttps://conductscience.org/library/genes/5552NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25751786

GET https://conductscience.org/api/papers/v1/25751786/references?page=2